"Designing Growth Strategies is in our DNA"

Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI101896

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Snapshot of Influenza Vaccine Rate – For Key Countries, 2025
    2. Annual Disease Burden of Influenza – For Key Countries/ Regions, 2024/2025
    3. New Product Launches, By Key Players
    4. Influenza Vaccination Campaigns/Programs Undertaken by Government
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    6. Pricing Analysis – By Key Brand/Key Players, By Key Countries, 2024/2025
    7. Snapshot of Pipeline Analysis of Influenza Vaccines
    8. Impact of COVID-19 on the Market
  5. Global Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Valency
      2. Canada
        1. By Valency
  7. Europe Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Valency
      2. Germany
        1. By Valency
      3. France
        1. By Valency
      4. Italy
        1. By Valency
      5. Spain
        1. By Valency
      6. Scandinavia
        1. By Valency
      7. Rest of Europe
        1. By Valency
  8. Asia Pacific Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Valency
      2. China
        1. By Valency
      3. India
        1. By Valency
      4. Australia
        1. By Valency
      5. Korea
        1. By Valency
      6. Rest of Asia Pacific
        1. By Valency 
  9. Latin America Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Valency
      2. Mexico
        1. By Valency
      3. Rest of Latin America
        1. By Valency 
  10. Middle East & Africa Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC Countries
        1. By Valency 
      2. South Africa
        1. By Valency
      3. Rest of Middle East & Africa
        1. By Valency
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. AstraZeneca
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. CSL Limited (Seqirus)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. GlaxoSmithKline plc
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sanofi
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. SINOVAC
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. BIKEN Co., Ltd.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbott
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Snapshot of Influenza Vaccine Rate – For Key Countries, 2025
    2. Annual Disease Burden of Influenza – For Key Countries/ Regions, 2024/2025
    3. New Product Launches, By Key Players
    4. Influenza Vaccination Campaigns/Programs Undertaken by Government
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    6. Pricing Analysis – By Key Brand/Key Players, By Key Countries, 2024/2025
    7. Snapshot of Pipeline Analysis of Influenza Vaccines
    8. Impact of COVID-19 on the Market
  5. Global Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Valency
      2. Canada
        1. By Valency
  7. Europe Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Valency
      2. Germany
        1. By Valency
      3. France
        1. By Valency
      4. Italy
        1. By Valency
      5. Spain
        1. By Valency
      6. Scandinavia
        1. By Valency
      7. Rest of Europe
        1. By Valency
  8. Asia Pacific Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Valency
      2. China
        1. By Valency
      3. India
        1. By Valency
      4. Australia
        1. By Valency
      5. Korea
        1. By Valency
      6. Rest of Asia Pacific
        1. By Valency 
  9. Latin America Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Valency
      2. Mexico
        1. By Valency
      3. Rest of Latin America
        1. By Valency 
  10. Middle East & Africa Influenza Vaccines Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC Countries
        1. By Valency 
      2. South Africa
        1. By Valency
      3. Rest of Middle East & Africa
        1. By Valency
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. AstraZeneca
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. CSL Limited (Seqirus)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. GlaxoSmithKline plc
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sanofi
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. SINOVAC
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. BIKEN Co., Ltd.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbott
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Influenza Vaccine Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 02: Global Influenza Vaccine Market Value Share (%), By Type, 2025 & 2034

Figure 03: Global Influenza Vaccine Market Value Share (%), By Valency, 2025 & 2034

Figure 04: Global Influenza Vaccine Market Value Share (%), By Age Group, 2025 & 2034

Figure 05: Global Influenza Vaccine Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 06: Global Influenza Vaccine Market Value Share (%), By Region, 2025 & 2034

Figure 07: North America Influenza Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 08: North America Influenza Vaccine Market Value Share (%), by Type, 2025

Figure 09: North America Influenza Vaccine Market Value (USD billion), by Valency, 2025 & 2034

Figure 10: North America Influenza Vaccine Market Value Share (%), by Valency, 2025

Figure 11: North America Influenza Vaccine Market Value (USD billion), by Age Group, 2025 & 2034

Figure 12: North America Influenza Vaccine Market Value Share (%), by Age Group, 2025

Figure 13: North America Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 14: North America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 15: North America Influenza Vaccine Market Value (USD billion), by Country, 2025 & 2034

Figure 16: North America Influenza Vaccine Market Value Share (%), by Country, 2025

Figure 17: Europe Influenza Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 18: Europe Influenza Vaccine Market Value Share (%), by Type, 2025

Figure 19: Europe Influenza Vaccine Market Value (USD billion), by Valency, 2025 & 2034

Figure 20: Europe Influenza Vaccine Market Value Share (%), by Valency, 2025

Figure 21: Europe Influenza Vaccine Market Value (USD billion), by Age Group, 2025 & 2034

Figure 22: Europe Influenza Vaccine Market Value Share (%), by Age Group, 2025

Figure 23: Europe Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 24: Europe Influenza Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 25: Europe Influenza Vaccine Market Value (USD billion), by Country, 2025 & 2034

Figure 26: Europe Influenza Vaccine Market Value Share (%), by Country, 2025

Figure 27: Asia Pacific Influenza Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 28: Asia Pacific Influenza Vaccine Market Value Share (%), by Type, 2025

Figure 29: Asia Pacific Influenza Vaccine Market Value (USD billion), by Valency, 2025 & 2034

Figure 30: Asia Pacific Influenza Vaccine Market Value Share (%), by Valency, 2025

Figure 31: Asia Pacific Influenza Vaccine Market Value (USD billion), by Age Group, 2025 & 2034

Figure 32: Asia Pacific Influenza Vaccine Market Value Share (%), by Age Group, 2025

Figure 33: Asia Pacific Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 34: Asia Pacific Influenza Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 35: Asia Pacific Influenza Vaccine Market Value (USD billion), by Country, 2025 & 2034

Figure 36: Asia Pacific Influenza Vaccine Market Value Share (%), by Country, 2025

Figure 37: Latin America Influenza Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 38: Latin America Influenza Vaccine Market Value Share (%), by Type, 2025

Figure 39: Latin America Influenza Vaccine Market Value (USD billion), by Valency, 2025 & 2034

Figure 40: Latin America Influenza Vaccine Market Value Share (%), by Valency, 2025

Figure 41: Latin America Influenza Vaccine Market Value (USD billion), by Age Group, 2025 & 2034

Figure 42: Latin America Influenza Vaccine Market Value Share (%), by Age Group, 2025

Figure 43: Latin America Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 44: Latin America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 45: Latin America Influenza Vaccine Market Value (USD billion), by Country, 2025 & 2034

Figure 46: Latin America Influenza Vaccine Market Value Share (%), by Country, 2025

Figure 47: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 48: Middle East & Africa Influenza Vaccine Market Value Share (%), by Type, 2025

Figure 49: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Valency, 2025 & 2034

Figure 50: Middle East & Africa Influenza Vaccine Market Value Share (%), by Valency, 2025

Figure 51: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Age Group, 2025 & 2034

Figure 52: Middle East & Africa Influenza Vaccine Market Value Share (%), by Age Group, 2025

Figure 53: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 54: Middle East & Africa Influenza Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 55: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Country, 2025 & 2034

Figure 56: Middle East & Africa Influenza Vaccine Market Value Share (%), by Country, 2025

Figure 57: Global Influenza Vaccine Market Share (%), 2025

Table 01: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 02: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 03: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2021-2034

Table 04: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 05: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 06: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 07: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 08: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2021-2034

Table 09: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 10: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 11: U.S. Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 12: Canada Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 13: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 14: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 15: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2021-2034

Table 16: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 17: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 18: Germany Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 19: U.K. Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 20: France Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 21: Italy Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 22: Spain Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 23: Scandinavia Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 24: Rest of Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 25: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 26: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 27: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2021-2034

Table 28: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 29: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 30: Japan Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 31: Korea Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 32: China Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 33: India Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 34: Australia Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 35: Rest of Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 36: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 37: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 38: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2021-2034

Table 39: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 40: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 41: Brazil Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 42: Mexico Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 43: Rest of Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 44: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 45: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 46: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2021-2034

Table 47: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 48: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 49: GCC Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 50: South Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Table 51: Rest of Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2021-2034

Influenza Vaccine Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 177
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports